Aficamten Significantly Improves Peak Oxygen Uptake in Obstructive Hypertrophic Cardiomyopathy
Treatment with the oral selective cardiac myosin inhibitor aficamten results in significantly...
Read MoreMay 17, 2024
Treatment with the oral selective cardiac myosin inhibitor aficamten results in significantly...
Read MoreMay 13, 2024
Tafamidis improves clinical outcomes in transthyretin amyloid cardiomyopathy (ATTR-CM), yet how tafamidis affects cardiac structure and function remains poorly described. This study prospectively analysed the effect of tafamidis...
Read MoreMay 10, 2024
THURSDAY, May 9, 2024 (HealthDay News) — In a new clinical guideline issued by the American...
Read MoreMar 29, 2024
Young adults prescribed stimulant medications for attention-deficit/hyperactivity disorder (ADHD)...
Read MoreMar 25, 2024
AI-ECG may have clinical implications and provide additional insight into general risk stratification among patients with Takotsubo cardiomyopathy.
Read MoreMar 7, 2024
Right ventricular (RV) pacing sometimes causes left ventricular (LV) systolic dysfunction, also known as pacing-induced cardiomyopathy (PICM). However, the association between specifically paced QRS morphology and PICM...
Read MoreFeb 12, 2024
Takotsubo cardiomyopathy (TTC), also known as stress-induced cardiomyopathy, resembles acute heart failure syndrome but lacks disease-specific diagnosis and treatment strategies. TTC accounts for approximately 5-6% of all...
Read MoreFeb 7, 2024
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works...
Read MoreFeb 2, 2024
1. In this randomized controlled trial, patients with transthyretin (TTR) amyloid cardiomyopathy...
Read MoreJan 29, 2024
An early and accurate diagnosis of septic cardiomyopathy is vital for improving the overall prognosis of sepsis. In our research, we aimed to identify signature genes and their immune connections in septic cardiomyopathy. By...
Read MoreJan 12, 2024
THURSDAY, Jan. 11, 2024 (HealthDay News) — Acoramidis yields a significantly better...
Read MoreJan 8, 2024
Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of sudden cardiac death (SCD) due to ventricular arrhythmias and other arrhythmias. Screening for arrhythmias is mandatory to assess the individual SCD risk,...
Read MoreJan 1, 2024
1. Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) managed with tafamidis showed...
Read MoreDec 28, 2023
The following is a summary of “Randomized Controlled Trial of Moderate‐ and High‐Intensity...
Read MoreNov 13, 2023
Numerous prognostic factors have been proposed for cardiac amyloidosis (CA). The knowledge about other subtypes of restrictive cardiomyopathy (RCM) is scant.To reveal the etiology, identify prognostic factors, and assess cardiac...
Read MoreNov 6, 2023
Dilated cardiomyopathy (DCM) is characterized by decreased systolic function and dilation of one or both ventricles, often leading to heart failure or sudden death. Two 10-month-old sibling Nova Scotia Duck Tolling Retrievers...
Read MoreOct 16, 2023
Dilated cardiomyopathy (DCM) is a severe, non-ischemic heart disease which ultimately results in...
Read MoreOct 16, 2023
It is well recognized that amyloid protein can infiltrate many regions of the body. This can...
Read MoreOct 16, 2023
There are few prospective reports of 1-year outcomes for women with peripartum cardiomyopathy (PPCM). We report findings from the European Society of Cardiology EURObservational Research Programme PPCM Registry.The registry...
Read MoreSep 15, 2023
Bookmark©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.